NEWS EN

EXPO 2020 DUBAI – MTM WILL BE PRESENT AT WETEX DUBAI

MTM lands in Dubai to support the Techinnova incubator during the Emirates experience. As part of the Ready2Expo Dubai project promoted by Promos Italia – the Italian Agency for Internationalisation, MTM – supported by the incubator – is flying to the Arab Emirates to take part in the 2021 edition of Wetex & Dubai Solar…
Read more

Investment in WALLLED – MTM and Techinnova

MTM s.r.l. is pleased to announce that it has invested in the innovative startup Wallled s.r.l.; the Techinnova incubator – through its Innogrow acceleration programme – also took part in the investment. Why did we invest? The Wallled team is proving, with increasingly concrete results, that it is able to combine its lighting expertise with…
Read more

MTM invests in process innovation.

MTM, which has been paying attention to the development trends of some key sectors in which it operates for years, is currently investing in the following sectors: energy, environment and tourism. In order to guarantee a better access to these sectors, after a careful analysis, it has focused on 3 innovative start-ups that have interesting…
Read more

inStrain profiles population microdiversity from metagenomic data and sensitively detects shared microbial strains

Nature Biotechnology, Published online: 18 January 2021; doi:10.1038/s41587-020-00797-0 A metagenome analysis tool identifies microbial strains within and between populations. Source: Nature Biotecnology

Research priorities for COVID-19 sensor technology

Nature Biotechnology, Published online: 18 January 2021; doi:10.1038/s41587-021-00816-8 Research priorities for COVID-19 sensor technology Source: Nature Biotecnology

Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson’s disease

Nature Medicine, Published online: 18 January 2021; doi:10.1038/s41591-020-01198-1 Reduced meningeal lymphatic flow detected in patients with idiopathic Parkinson’s disease compared to patients with atypical Parkinsonian disorders and cognitively normal controls. Source: Nature Medicine

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

Nature Medicine, Published online: 18 January 2021; doi:10.1038/s41591-020-01189-2 Exploratory analyses from the phase 2 randomized SAFIR02-IMMUNO trial identify biomarkers associated with improved outcomes to durvalumab as compared to maintenance chemotherapy in patients with triple-negative breast cancer. Source: Nature Medicine

High-frequency neuromodulation improves obsessive–compulsive behavior

Nature Medicine, Published online: 18 January 2021; doi:10.1038/s41591-020-01173-w Selective and personalized neuromodulation of orbitofrontal beta–gamma rhythms in humans, achieved with an alternating current, robustly attenuates obsessive–compulsive behavior for 3 months. Source: Nature Medicine

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Nature Medicine, Published online: 18 January 2021; doi:10.1038/s41591-020-01168-7 Functional interplay of sex hormones in estrogen receptor–positive breast cancer unveils the therapeutic potential of androgen receptor agonists. Source: Nature Medicine

State-dependent responses to intracranial brain stimulation in a patient with depression

Nature Medicine, Published online: 18 January 2021; doi:10.1038/s41591-020-01175-8 Acute mapping of responses to focal electrical neuromodulation in a patient with treatment-resistant depression reveals distinct mood and symptom changes that are highly context dependent. Source: Nature Medicine